Pharmacy Is Dead
Pharmacy Is DeadThe CVS/Aetna deal won’t kill traditional pharmacy—it just shows that it’s already dead.
Walgreens/Rite Aid Merger Scrapped
Walgreens/Rite Aid Merger ScrappedAfter anti-trust woes, the acquisition is thrown out and Walgreens buys over 2,000 stores.
Fred's Could Help Rite Aid/Walgreens Deal Go ThroughThe chain has said it remains committed to buying Rite Aid stores.
Akorn forced to sell marketing rights to 5 drugsThe Federal Trade Commission (FTC) is requiring Akorn Enterprises’ subsidiary Hi-Tech Pharmacal to sell the marketing rights for five generic drugs to Watson Laboratories to settle federal charges that Akorn’s acquisition of Hi-Tech was anticompetitive.
Court overturns first physician-practice acquisition by health systemMarket power unravels Idaho acquisition
FTC can challenge healthcare practice mergersDr. Derm owns 15 dermatology practices. Dr. Skin owns 12 similar practices. Recently a venture capitalist bought all of these practices and merged them as one practice. All of the dermatologists were given a 20-mile, two-year restrictive covenant.
Supreme Court rules against “pay-for-delay”The US Supreme Court today stated that pay-for-delay agreements between brand name drug companies and generic manufacturers are subject to antitrust scrutiny.
U.S. Supreme Court hears arguments on pay-for-delay settlementsThe U.S. Supreme Court will have to decide whether reverse payments, also known as “pay-for-delay settlements,” between branded and generic drug companies are anticompetitive and violate U.S. antitrust law.
Quality, safety concerns